FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease

For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.

Read the full article on diagnosticimaging.com